• http://fprtbio.dreamhosters.com/wp/wp-content/uploads/2014/04/1-960x350.jpg
  • http://fprtbio.dreamhosters.com/wp/wp-content/uploads/2014/04/2-960x350.jpg
  • http://fprtbio.dreamhosters.com/wp/wp-content/uploads/2014/04/6-top-960x350.jpg
  • http://fprtbio.dreamhosters.com/wp/wp-content/uploads/2014/04/4-960x350.jpg
  • http://fprtbio.dreamhosters.com/wp/wp-content/uploads/2014/04/5-960x350.jpg
  • http://fprtbio.dreamhosters.com/wp/wp-content/uploads/2014/04/6-bottom-960x350.jpg
  • http://fprtbio.dreamhosters.com/wp/wp-content/uploads/2014/04/3-960x350.jpg
http://fprtbio.dreamhosters.com/wp/wp-content/themes/flare/images/shadow-1.png
FPRT Bio is developing new ways to treat debilitating neurodegenerative diseases. Our lead molecule, XPro1595, is a first in class protein therapeutic that targets tumor necrosis factor (TNF-α) by a novel mechanism not available to currently approved anti-TNF therapeutics.

FPRT Bio is a biotechnology company developing novel therapies for the treatment of neurodegenerative diseases, including ALS (Lou Gehrig’s Disease), Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis.